The authors also report a small increase in the SHh pathway inhibitor PTCH1 following Wnt3a stimulation of CML cells, suggesting that Wnt signaling may play a negative regulatory role on the SHh pathway [104]. The gene discussed is WNT3A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.